Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Magro CM, Klinger DM, Adams PW, Orosz CG, Pope-Harman AL, W Waldman J, et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant. 2003;3(10):1264-72.

Ding Y, Chen D, Tarcsafalvi A, Su R, Qin L, Bromberg JS. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J Immunol. 2003;170(3):1383-91.

Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res. 2003;1(10):707-15.

Magro CM, Ross P, Kelsey M, W Waldman J, Pope-Harman A. Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant. 2003;3(9):1155-66.

Murray SA, Zheng H, Gu L, Xiao Z-. IGF-1 activates p21 to inhibit UV-induced cell death. Oncogene. 2003;22(11):1703-11.

Brenner RM, Slayden OD, Rodgers WH, Critchley HO, Carroll R, Nie XJ, et al. Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium. Hum Reprod. 2003;18(6):1185-93.

Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2003:497-519.

Nucci MR, Castrillon DH, Bai H, Quade BJ, Ince TA, Genest DR, et al. Biomarkers in diagnostic obstetric and gynecologic pathology: a review. Adv Anat Pathol. 2003;10(2):55-68.

2002

Ince TA, Weinberg RA. Functional genomics and the breast cancer problem. Cancer Cell. 2002;1(1):15-7.

Sellers WR, Loda M. The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? Cancer Cell. 2002;2(5):349-50.